Background: Ovarian cancer is a complicated malady associated with cancer stem cells (CSCs) contributing to 238,700 estimated new cases and 151,900 deaths per year, worldwide. CSCs comprise a tiny fraction of tumor-bulk responsible for cancer recurrence and eventual mortality. CSCs or tumor initiating cells are responsible for self-renewal, differentiation and proliferative potential, tumor initiation capability, its progression, drug resistance and metastatic spread. Although several biomarkers are implicated in these processes, their distribution within the ovary and association with single cell type has neither been established nor demonstrated across ovarian tumor developmental stages. Therefore, precise identification, thorough characterization and effective targeted destruction of dormant and highly proliferating potent CSC populations is an immediate need. Results: In view of this, distribution of various CSC (ALDH1/2, C-KIT, CD133, CD24 and CD44) and cell proliferation (KI67) specific markers in the ovarian surface epithelium (OSE) and cortex regions in normal ovary, and benign, borderline and high grade metastatic ovarian tumors by immuno-histochemistry and confocal microscopy was studied. We further confirmed their expression by RT-PCR analysis. Co-expression analysis of stem cell (OCT4, SSEA4) and CSC (ALDH1/2, CD44 and LGR5) markers with proliferation marker (KI67) in HG tumors revealed dual positive proliferating stem and CSCs, few non-proliferating stem/CSC (SSEA4
Background
While constituting only 3% of the cancer cases affecting women, ovarian cancer is a fatal malady due to its unpredictable prognosis, poor refractory outcome, oncotherapeutic resistance, metastatic spread and ultimate relapse with no signs of improvement in patient survival to date [1] . In recent years, existence of various cancer stem cells (CSCs) in ovarian tumor, as well as in ascites from patients with ovarian cancer have been reported as a cause of tumor relapse and recurrence, thus imposing a clinical problem [2] [3] [4] . Various specific markers including ALDH1/ 2, CD133, CD117, CD24, CD34, CD44, CD133, EpCAM, LGR5 and LY6A have been employed for isolation and characterization of ovarian CSCs from ovarian cancer cell lines, patients' tumors and ascites [5, 6] . CSCs also known as tumor initiating/propagating cells, as per the CSC hypothesis, suggest hierarchical organization of cell subsets that possess self-renewal potential, tumor initiation capability and tumor progression [7] . Presently, it is established that tumor is comprised of heterogeneous cancer cell populations at various stages of differentiation and a tiny fraction of CSC populations. This heterogeneity leads to a serious bottleneck for effectively targeting these highly dynamic, transitioning populations of CSCs. Existence of diverse CSC populations with stem cell like characteristics at a given point and a cross talk between tissue microenvironment, various genetic and non-genetic (epigenetic) factors and dysregulation between these mechanisms impose drug resistance, tumor recurrence and metastasis [6, 8] . Combin hi (colon cancer) and other solid tumors have been identified (reviewed in [9] ). While a stage-specific identity of ovarian CSCs is missing, their expression in normal ovary and at various stages of tumorigenesis and the marker profile for highly proliferating CSCs in metastatic stage in the context of ovarian stem cells remains unknown. Hence purpose of present study is to (i) identify stem cells residing in normal ovary versus ovarian tumors including benign (BN), borderline (BL) and high grade (HG) (malignant stage) and (ii) delineate if highly proliferating cells in HG ovarian tumor are differentiated cancer cells and/or (cancer) stem cell populations per se by using a panel of markers.
In our present study, we provide a glimpse of the diverse populations of cells with stem cell characteristics and proliferating cancer cells persisting in normal ovary and their (probable) counterparts in various stages of tumorigenesis. To the best of our knowledge, it is the first report showing/ describing in detail for the existence, distribution and abundance of various stem cell populations in normal ovary and CSCs in ovarian tumors at various stages of tumorigenesis using several relevant markers, thus implicating the possibility of good (normal) stem cells going bad and ugly (as CSCs). Understanding the precise mechanisms responsible for and the factors influencing initiation of this probable cellular transformation and subtle differences between the 'good, and the bad and ugly' would lead us to achieve further milestones in cancer stem cell research.
Methods

Ethical permission for obtaining normal ovarian and tumor tissue
Tissue samples were collected from ovarian cancer patients admitted to the James Graham Brown Cancer Center, University of Louisville. Procedures followed were as per the ethical protocols approved by the Institutional Review Board (IRB). were obtained from institutional bio-repository and were used for reverse transcription polymerase chain reaction (RT-PCR) analysis. All the experiments were performed in triplicates. Chemicals, reagents and plastic-ware were procured from Sigma-Aldrich or stated otherwise.
Immunohistochemistry of ovarian tissue and tumor sections
Paraffin embedded ovarian sections from NO, BN, BL and HG were prepared by standard histology procedures. Sections were de-paraffinized in xylene. Endogenous peroxidase activity (abundant in the red blood cells) was quenched by incubating the sections in 3% hydrogen peroxide in 100% methanol for 60 min followed by rehydration in alcohol grades. Antigen retrieval and staining of each tissue section for specific stem cell/CSC marker was performed as described previously [10] . Immuno-staining pattern was assessed by scanning the slides using an Aperio Scanscope digital pathology scanner (Leica Biosystems) and Olympus IX71 inverted microscope (Olympus, Tokyo, Japan). Representative images were photographed and specific staining signals were documented.
Immunofluorescence staining, co-localization and confocal microscopic analysis Protocol for immunofluorescence staining and dual staining (co-localization studies) was similar to immuno-histochemistry. Endogenous peroxidase (3% H 2 O 2 ) quenching step was omitted during immunofluorescence staining and intermediate washing steps were performed using PBS containing 0.5% BSA as described previously [10] . Antibody dilution for each was optimized to provide specific binding with no background as detailed in Table 1 . Tissue sections were viewed using Nikon (Eclipse TI) confocal microscope and documented using NIS Elements AR software (version 4.5.1). The slides were thoroughly scanned under the confocal microscope and representative 10-12 images for each section were captured at 40X with 2.5X zoom to focus upon positive signals emitted by small 5-10 μm (cancer) stem cells of interest in each sample. Dual immuno-fluore scence protocol was identical to immuno-fluorescence protocol, except each of the two primary and secondary antibodies were applied simultaneously to each tissue section on day 1 and 2 respectively. Alexa Fluor 488 and 568-labeled anti-mouse and anti-rabbit IgG were used at 1:500-1:1000 dilution followed by counter staining with nuclear dye DAPI. The sections were examined under confocal microscope. Uniform instrument parameters were employed for confocal microscopy imaging for each antibody and on an average 7-10 images (per sample/antibody) were captured, further analysed and compiled to prepare the composite panels comprising of individual cells captured from various regions of a single field or from multiple fields that were scanned and documented.
RNA extraction, cDNA preparation and RT-PCR
RNA from NO, BN, BL and HG tissues was prepared, purified and subjected to RT-PCR amplification using specific primers (detailed in Table 2 ) and conditions (described in [10] ). Amplified products were analyzed on 2% agarose gels.
Results
In our present study, we focused on understanding the distribution of various CSC-specific markers in normal ovary and various stages of ovarian tumorigenesis (BN, BL and HG), and characterization of CSCs in HG metastatic ovarian cancer tissues (Figs. 1A, B, 2A Table S1 and Additional file 5: Table S2 Immuno-histochemical analysis of CSC markers in normal ovary and tumor tissues A characteristic but unique distribution pattern for each marker namely C-KIT/CD117, CD133, CD44, CD24 and ALDH1/2 (Figs. 1A, 2A and 3A, Additional file 1: Figure S1 , Additional file 3: Figure S3 ) within OSE layer and cortex regions both were noticed (detailed in Additional file 4: Table S1 ). 
C-KIT/CD117
C-KIT/CD117 is an oncogene (a tyrosine kinase receptor) and is significantly over expressed in malignant ovarian tumors and associated with poor patient survival and worse outcome [11] [12] [13] . It is expressed in fibroblast-like stromal cells (possibly of MSC origin) in ovarian carcinoma [14] in addition to normal OSE [15] , thus making it imperative to further assess its expression in various CSC subsets and decipher its precise functional role in tumorigenesis. In our studies, we observed that C-KIT/CD117 was localized in OSE layer in NO, BN, BL and HG. CD117 + cells per field were found to be higher in BL and HG compared to NO and BN. In addition, large CD117 + cell clusters (tumor like) were visible in BL and HG. In contrast, NO and BN showed CD117 expression as single cells. Larger cells with bright and specific positive signals in the layer beneath OSE were visible in BN, while multiple cells in cluster detached near OSE (multi) layer in BL with specific foci. We observed CD117 + specific signals with bright staining spread across the cortex. Specific single or multiple cells forming a non-uniform pattern were more prominent in BL and HG compared to NO and BN (Fig. 1A) , merely suggesting their putative role in ovarian tumorigenesis.
CD133
CD133/Prominin is a five-trans-membrane domain glycoprotein with potential role in organization of plasma membrane. CD133 + cells possess high clonogenic capability and are implicated in tumor development and chemo-resistance [16] [17] [18] [19] . High levels of CD133 expression have been reported in primary ovarian tumor compared to NO and BN [20] . Surprisingly, lower levels of expression in metastatic HG have been reported [21] . In our studies, using the CD133-specific antibody, we observed the presence of bright and uniformly distributed CD133 + cells prominently in OSE layer throughout NO, BN, BL and HG. However, multiple clusters of CD133 + cells were visible in OSE layer of both BL and HG. Single or multiple CD133 + cells were distributed throughout the cortex in NO, BN, whereas, sparse and isolated CD133 + cells were detected in BL and HG cortex ( Fig. 2A) .
CD44
CD44 is expressed in lymphoid epithelial cells as well as implicated in various cellular processes such as cell-cell interaction, apoptosis, migration, invasion, tumorigenesis and metastasis. Owing to these properties, CD44 serves as effective tool for pathological diagnosis and prognostic prediction of ovarian cancer in a clinical setup. [22, 23] (Fig. 3A) .
CD24
It is a sialo-glycoprotein expressed by mature granulocytes, B cells and regulates their growth and differentiation. High levels of CD24 expression and its association with quiescence, chemo-resistance, tumor initiation, and metastatis have been reported in several cancers [24, 25] . Despite its absence in NO OSE and high expression in ovarian carcinoma, it is speculated as a non-specific + cells in cortex were also observed. White scale bar = 50 μm; blue scale bar = 10 μm. Secondary antibody employed was conjugated with Alexa fluor 568 and tissue sections were counterstained with nucleus specific dye DAPI ovarian tumor marker [26] . In recent studies by Korkolopoulou et al. [27] reported CD24 as a key molecule in metastasis and EMT process in tumor tissues and Caov3 cell line, suggesting its role in dissemination of ovarian CSCs to peritoneal cavity; therefore, it may serve as a potential therapeutic target. However, none of the studies correlated it with ovarian stem cells in context to localization of CD24 + cells in OSE or cortex region. Therefore, to define the distribution of CD24 + cells in normal ovary and at different stages of ovarian tumorigenesis, we analysed its expression. CD24 + cells were visible in OSE layer of BN, BL and HG, while no signal was detected in NO. NO, BL and HG cortex specially revealed small regions/foci with prominent positive signals while the surrounding region showed undetectable signals confirming the staining specificity. Single -spherical, and multiple-spindle and elliptical shaped CD24 + cells were observed (Additional file 1: Figure S1 ).
KI67
Although, various studies demonstrate correlation of KI67 expression with shorter disease free survival as well as overall patient survival (OS) [28] [29] [30] [31] [32] , discrepancy among different studies prevail (discussed in [32] ). Disputing authenticity of KI67 as a prognostic marker is attributed to onco-therapy regimen among different patients, patient status (chemo-naive versus chemo-treated), variable staining procedures adopted, technical and methodology related variations such as antibodies, specimen type and fixative type used; antigen retrieval procedure and scoring methods employed by different investigators [29, 33] . Therefore, a detailed study to define its role and significance in tumorigenesis is required.
In our study, we observed diffused staining and existence of rare KI67 + cells in NO tissues, while highly specific KI67 + cells within OSE layer in BN, BL and HG as single, isolated-spherical while spindle shaped multiple-clustered or duplet cells were observed within the cortex (Additional file 3: Figure S3 ). Variable shaped nuclear and cytoplasmic/ membrane bound KI67 + signals in HG OSE and cortex revealed numerous proliferating cells (cancer cells and/or CSCs). Overall small spherical cells (~5 μm, which resemble VSELs [34] and larger spindle shaped (~10 μm) cells were prominently observed, revealing multiple CSC specific markers, suggesting dynamic hierarchy persisting similar to distinct populations described earlier in NO [35] [36] [37] .
Immunofluorescence staining of CSC markers in normal ovary and ovarian tumor To confirm our results from immuno-histochemical analysis and to define the sub-cellular (membrane, cytoplasmic and nuclear) localization, we performed immuno-fluore scence analysis using specific antibody for each of the marker followed by high resolution confocal microscopy. + cells larger than 10 μm were typically detected in BN cortex (Fig. 1B) . These results are consistent with immuno-histochemical staining reported above (Fig. 1A) .
CD133
Single and multi-layered CD133 + cells in OSE of NO, BN, BL and HG tissues were clearly visible with + cells/field of focus in HG (Fig. 2B) . These results are consistent with immuno-histochemical staining reported above ( Fig. 2A) .
CD44
Multiple CD44
+ cell membrane bound signals in NO, BN single isolated cells and cell clusters were visible especially in BL and HG OSE layers. Cortex also revealed single and multiple cells in proximity in specific regions. Multi-nucleated cell clusters were obvious in cortex of NO, BN and HG, while single isolated (≤10 μm) cells (Fig. 3B) . These results are consistent with immuno-histochemical staining reported above (Fig. 3A) .
ALDH1/2
Single/multi-layered OSE cells revealed ALDH1/2 + cells with spherical and elliptical morphology in NO and BN. BL and HG OSE revealed spherical and elliptical shaped cells in clusters in addition to single isolated cells. Numerous ALDH1/2 + cells were observed in HG cortex as compared to NO, BN and BL cortex (Additional file 2: Figure S2 ). Most cells exhibited cytoplasmic signals while some cells specially noticed in NO and HG cortex revealed nuclear ALDH1/2 + signals. Distribution of ALDH1/2 + CSCs implicated in tumor progression and metastasis was recently shown by immunohistochemistry in ovarian tumors and in vitro in context to antitumor effect of novel drugs targeting CSCs [38] . Negative controls for mouse and rabbit antibodies were employed by omitting primary antibody (Additional file 6: Figure S4) .
A detailed analysis of cellular phenotype and further association of cells reported above with known ovarian germline stem cells is prerogative. Thus characteristic distribution pattern of various markers signifies specific CSC populations distinctly distributed within the tumor tissues with an aim to probably perform specific functional roles in tumor progression and metastasis is speculated. This may form the basis for further analysis of each sub-population in terms of their mechanisms adopted, their functional roles and significance in the process of tumorigenesis and metastatic spread. This study in turn may aid the identification of effective therapeutic targets.
Co-expression of stem and CSC specific markers with proliferation marker in high grade ovarian tumor tissue sections
It is vital to understand cellular identity of proliferating cell fraction in HG tumors. Since CSCs have been reported to play critical role in metastasis, therefore, to comprehend the phenomenon of metastasis and ascites formation, we performed co-expression of KI67 with stem cell and CSC specific markers. In our study, we observed that pluripotency related stem cell marker OCT4 + cells were also observed in the cortex region. KI67 was expressed in active phases of cell cycle [G (1) , S, G (2) was predominantly expressed in both OSE layer (Fig. 4a-d) and cortex (Fig. 4e-h) . In both locations, OCT4 + cells also expressed proliferation marker KI67 with mostly nuclear signals for both markers while few cells with cytoplasmic KI67 signals (blue asterisk) were detected. Expression of both OCT4 and KI67 was found to be variable. A few OCT4 + cells expressed low/undetectable levels of KI67 (white asterisk), possibly signifying different stages of differentiation of CSCs. Other surface marker typical of pluripotent stem cells that is SSEA4 (Fig. 5 ) was found to be expressed in both OSE layer (Fig. 5a-d) and cortex (Fig. 5e-h [36, 39] .
CD44 (CSC-surface marker) positive cells showed co-expression of KI67. These cells revealed nuclear as well as cytoplasmic and membrane bound (blue asterisk) KI67 signals in cortex. A large number of bright dual positive cells were detected in the cortex region (Fig. 6) . Some of the KI67 + cells revealed undetectable CD44 staining (white asterisk), suggesting variable expression of CD44 marker at various stages of proliferation and differentiation of cancer cells as well as CSCs. Similarly LGR5 (a surface G-protein coupled receptor) revealed its presence in OSE layer as well as cortex region of HG tumor.
LGR5 + cells in OSE layer exhibited membrane localization, whereas, KI67 + signals revealed both nuclear as well as cytoplasmic localization (blue asterisk). Cell clusters positive for expression of both markers (LGR5 + /KI67 + ) were found in OSE layer as well as in cortex region suggesting proliferating CSCs. ALDH1/2 + /KI67 + cells were mainly localized in OSE layer. Many spindle shaped KI67 − cells (white asterisk) expressing ALDH1/2 were observed in the cortex (Fig. 8) , probably suggesting non-proliferating CSC population within the cortex. However further in-depth study to confirm this hypothesis is required. Negative controls for mouse and rabbit antibodies were employed by omitting primary antibody for both immuno-staining methods (Additional file 6: Figure S4 ).
RT-PCR amplification of stem cell, CSC specific transcripts and proliferation marker in normal ovarian and tumor tissues
To confirm for the existence of various CSC markers in ovarian tissues at various stages of ovarian tumorigenesis, we performed RT-PCR amplification of each marker gene using specific primers. As shown in Fig. 9 , amplified gene products of expected size for CSC and proliferation specific markers were detected in most samples analysed. We used four normal ovarian (NO) tissues and four sets of patient tissues belonging to BN, BL, and HG tumors. RT-PCR analysis without cDNA template served as a negative control. RT-PCR analysis presents a semi-quantitative measure of mRNA transcript copy number expressed across various tissues. RT-PCR analysis of normal and tumor tissues confirmed the expression observed by both immuno-histochemical and immuno-fluorescence methods for each marker. As expected, some variation in the expression of each marker gene was observed among patients, but tumor stage-specific differences in expression of marker genes was not obvious due to immense cell heterogeneity within tumor tissues and lack of RT-PCR analysis on enriched cell populations per se (Fig. 9) .
Discussion
The CSC theory put forth initially by Virchow and Cohnheim hypothesized CSCs as "dormant embryonic tissue remnants", which later was replaced by the concept of "tissue specific stem cells as cancer cell origin" [40] . The adult human OSE is described as a germinal layer [41] , and is implicated in possessing primitive germ cells/precursor cells and their differentiation into germline cells. Furthermore, both quiescent and actively cycling stem cell populations are reported to exist in adult tissues such as bone marrow, skin, intestinal epithelium and hair follicle [42] . Several investigators have generated significant knowledge about germline stem cells in normal physiology and CSCs in tumors per se, however, several aspects in ovarian CSCs remain unknown to date. These include: i) whether CSCs are harboured within surface epithelium lining of the ovary, ii) they exist in the interior stroma/cortex region as well, iii) whether they migrate from the germinal layer to the interior, and iv) whether there is independent or simultaneous infiltration of stem cells from neighbouring reproductive organs (i.e. extra ovarian sites). An unequivocal opinion regarding the true cell of origin for epithelial ovarian cancer fails to exist because the OSE layer and oviductal fimbriae both share a common origin of transitional epithelium with incomplete commitment making these zones susceptible to neoplastic transformation [43] . While extra-ovarian source i.e. oviductal epithelium or fallopian tube fimbrial cells [44, 45] were suggested in human ovarian cancer; at the same time hilum region of mouse ovary, the transitional (or junction) area between OSE, mesothelium and tubal (oviductal) epithelium were proposed as the putative stem cell niche with implications in malignant transformation [46] . Lack of common histological parameters between normal ovary and tumors and difficulty to identify reproducible precursor lesions [45] in the ovary instigate further comprehensive research in this direction.
Present study and our recent publication [10] suggest for the existence of stem cell populations with CSC specific characteristics and many proliferating cells, alongside subsets of non-proliferating (probably dormant) stem cells (i.e. KI67 − ) expressing stem and CSC profile. Intriguingly stem cell subsets/compartments in normal ovary shared CSC specific markers expressed in tumors; while tumors possessed stem cell specific markers, thus implicating probable involvement of normal ovarian stem cells in the transformation and initiation of cancer (as proposed recently by Kenda-Suster et al. [47] in serous ovarian carcinoma). On similar lines in our recent study, we reported existence of differentially expressed germ line (stem cell) markers in CSCs (ovarian tumor) and stem cells (normal ovary) [10] . Other past studies suggest that OSE and cortex from normal adult ovarian tissues possess (OCT4 + , SSEA4 + ) tiny, spherical, stem cells and committed progenitor populations [36, 39, 48] which undergo asymmetric cell division [49] and upon proliferation form germ cell nests/ clusters [39, 49] . Similar cell clusters were observed in our recent [10] and current study possibly indicating proliferating stem cells persisting not only in normal ovary but present in ovarian tumor OSE and probably implicated in tumorigenesis as recently suggested by Virant Klun and group [50, 51] .
CSC heterogeneity
In present study, CSC sub-populations were detected by immuno-staining for CSC specific markers and co-expression analysis of same with proliferation marker KI67 to analyse the distribution, abundance and heterogeneity of persisting cell types within OSE and cortex regions of both normal ovary and ovarian cancer tissues at various stages of tumorigenesis. We did not investigate tumor progression from a particular stage to the next and associated changes in terms of CSC profile, but employed archival and fresh patient samples surgically excised at the Cancer Center, meeting the criteria of representing various stages of tumor development (BN, BL, HG) besides normal sample (NO) for immuno-staining and RT-PCR studies. We investigated by RT-PCR the presence of transcripts for each marker using specific primers. Immuno-staining of each marker (Figs. 1, 2 and 3 , Additional file 1: Figure S1 , Additional file 2: Figure S2 and Additional file 3: Figure S3 ) with respect to differential marker expression, distribution of signals and co-localization with proliferation marker KI67, detected heterogeneous sub-populations of cells (Figs. 4, 5, 6, 7 and 8) . This scenario correlates to certain extent (if not completely) and possibly justifies the variation in expression of various markers observed by RT-PCR (Fig. 9) . A variable level of expression for each marker gene was observed in patients' tumor tissues, which could be the result of presence of heterogeneous mixture of tumor cells in various stages of differentiation along with a tiny fraction of CSCs. Such variability in expression of each CSC marker, distinct phenotype, heterogeneity in stemness status etc. have been recently reviewed in ovarian CSCs [52] . On similar lines the findings by Inoue et al. [53] where they demonstrated a variable expression pattern of epithelial mesenchymal transition (EMT) marker E-cadherin within female genital tissues from benign and malignant tumors compared to normal ovaries substantiates the variability factor in present study results. Precise gene expression profiles of individual cells comprising of tumor tissue may be quite variable and hence representing differential levels of expression and hence collectively all tumor cells contribute to heterogeneous cell types and thus variable representation of gene expression.
The CSC hypothesis proposes bi-directional inter-conversion between stem and non-stem compartments in order to sustain tumorigenesis and establish multi-lineage differentiation into different tumor cell types [54] . However, exact mechanism to explain such lineage differentiation remains unknown. OCT4 med/low , CD44 hi , CD24
+ hierarchy of breast cancer cells have been reported recently [55] . Schwede et al. [56] characterized serous ovarian tumor cells, and co-related populations of stem cell like subtype in HG serous tumors to poor patient survival than the other differentiated subtype identified with mixed histology. Expression of stem cell markers (OCT4, SOX2, NANOG, NESTIN, ABCG2, CD133 and CD117) in ovarian cancer (sphere cells) represent their tumorigenic potential, and resistance to cisplatin, paclitaxel, adriamycin and methotrexate, which highlights the significance of "stemness" of cancer cells [17] . Similar to our current observations of two distinct populations of (spherical 5 μm and elliptical 10 μm) cells, recently two cell subsets with epithelial and stromal gene signatures respectively were detected in HG serous ovarian cancer exhibiting variable gene expression [57] . More recently, Ahmed et al. [58] based on proteomic signatures, reported activation/enrichment of specific pathways related to energy, metabolism and DNA repair in ascites derived tumor cells. Collectively these studies indicate persistence of heterogeneous CSC populations following a dynamic hierarchy possibly ordained to perform specific functions or cell rescue operations upon their exposure to onco-therapy. However, these reports fail to present a clear scenario of tumor progression associated phenotypic and genotypic changes in CSCs (specifically) in a stage-specific fashion. Recently, we reported presence of small spherical (~5 μm) and elliptical/spindle-shaped (≥ 10 μm) cells variably expressing CSC, and germline stem cell specific markers in normal ovarian and tumor tissues [10] . However, proliferation status of these (cancer) stem cell subsets especially in HG tumors (with high metastatic potential) remains unknown to date. To address this question, in our present study, we co-localized KI67 with stem and CSC specific markers and observed co-expression of KI67 and OCT4 + with pro-tumorigenic gene expression profile were reported in pancreatic ductal adenocarcinoma [64, 65] . In an independent study, Paula et al. [66] + co-expressing putative CSC markers in prostate carcinoma. Consistent with these studies, expression of various stem and CSC-specific markers such as OCT4, SSEA4, ALDH, CD117, CD133, CD44, CD24, and LGR5 in our study, suggests presence of various CSC populations with characteristics which may explain heterogeneity, aggressiveness and metastatic potential of ovarian cancer. However, it remains unknown from our studies, if CSCs present in OSE layer migrate to ovarian cortex and progress to cancer or the stem cells locally present in the cortex region (or any migrating from extra-ovarian sites) undergo transformation and result into tumor development. The possible involvement of stem cells/CSCs from organs of extra-ovarian origin requires thorough and systematic investigation which may add novel dimension in understanding the complicated disease of ovarian cancer and explore the putative cells of origin. Tracking specific (cancer) stem cell sub populations across different tumor stages in comparison with normal ovary and further in-depth studies may provide greater clarity of this phenomenon. However, the choice of stem/CSC population (s) to chase their trafficking is interesting and will be part of our future study.
Conclusions
To the best of our knowledge this study is the first attempt to investigate putative stem cell and CSC specific markers expressing and actively proliferating cell populations by dual labelling besides a stage-wise characterization of tumours compared to normal ovary focussing on OSE and cortex regions. Based on co-expression studies we found existence of dual positive proliferating stem cells and CSCs, few dormant stem/ CSCs (SSEA4 + /KI67 − and ALDH1/2 + /KI67 − ) and only KI67 + cells signifying dynamic populations and interesting cellular hierarchy in the cortex region. It is only speculated that these dynamic cell populations/subsets are probably differentiating or propagating particular clone to serve specific function which was recently explained on the basis of guidance by micro environmental cues and selective pressures as per Darwinian theory [68] . However, this speculation with our study perspective requires further rigorous investigation.
Based on our studies, we conclude that various sub-populations of stem cells (in normal ovary) and CSCs (in ovarian tumor) exist in both OSE and cortex regions of the human ovary. We propose that stem cells present in the ovary may be undergoing transformation due to changes in microenvironment and cell signalling mechanisms and result into CSCs, which progress to tumor development and metastatic spread. This hypothesis needs to be tested and is under investigation in our laboratory. Our study thus offers a stepping-stone towards further quantitative evaluation of CSC sub-populations predominant at various tumor stages (especially metastatic stage) and associated mechanisms to aid early detection, diagnosis and devise apt therapeutic modalities to curb recurrence. 
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